Company Profiles

driven by the PitchBook Platform

Celvive

Description

Developer of technology for treatment of chronic spinal cord injuries with their own adult stem cells. The company develops a technology for the isolation and use of autologous cellular therapy for regenerative medicine applications.

2010

Founded

PRIVATE

Status

Seed

Latest Deal Type

$500k

Latest Deal Amount

$500k

Total Amount Raised

1

Investors

Description

Developer of technology for treatment of chronic spinal cord injuries with their own adult stem cells. The company develops a technology for the isolation and use of autologous cellular therapy for regenerative medicine applications.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

120 Albany Street Tower II, Suite 850 New Brunswick, NJ 08901United States +1 (908) 731-6610
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Celvive's full profile, request a free trial.

    Celvive Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Celvive Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Foundation Venture Capital GroupVenture CapitalMinority000 0000000 0000
    Foundation Venture Capital Group Venture Capital

    Celvive Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Anthony Razavi Ph.DInterim Chief Executive Officer & Chief Scientific Officer
    Kamana Misra Ph.DDirector, Research & Development
    Anthony Razavi Ph.D Interim Chief Executive Officer & Chief Scientific Officer
    Kamana Misra Ph.D Director, Research & Development

    Celvive Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    James GolubieskiFoundation Venture Capital GroupBoard Member000 0000
    James Golubieski Board Member Foundation Venture Capital Group
    Request full access to PitchBook